Medeonföretag

Ascelia Pharma (Alumni)

Ascelia is an oncology-dedicated drug development company focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. Ascelia´s strategy is to develop and make available to patients a portfolio of differentiated, underappreciated and de-risked product candidates addressing unmet medical needs in cancer and cancer-related diseases. Ascelia is fully focused on two clinical-stage product candidates under development: Mangoral and Oncoral.

KONTAKT
Magnus Corfitzen, CEO 
T +46 735 179 110
E info@ascelia.com
W www.ascelia.com

ADRESS
Ascelia Pharma AB
Hyllie Boulevard 34
SE-215 32 Malmö